Drug Profile
IPR 6001
Latest Information Update: 20 Aug 2002
Price :
$50
*
At a glance
- Originator Institute for Pharmaceutical Research
- Class Analgesics; Anti-inflammatories; Antirheumatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation; Pain; Rheumatic disorders
Most Recent Events
- 23 Jun 1998 Phase-II clinical trials for Inflammation in Germany (Topical)
- 23 Jun 1998 Phase-II clinical trials for Inflammation in Switzerland (Topical)
- 23 Jun 1998 Phase-II clinical trials for Pain in Germany (Topical)